Articles in IPOs

Renaissance Capital

Sky Solar Holdings sets terms for $138 million IPO

Sky Solar Holdings, an independent power producer with solar assets mainly in Greece and Japan, announced terms for its IPO on Wednesday. The Hong Kong based company plans to raise $138 million by... Read >>

Renaissance Capital

Female sexual dysfunction biotech S1 Biopharma sets terms for $36 million IPO

S1 Biopharma, a biotech developing a combined therapy of existing drugs for female sexual dysfunction, announced terms for its IPO on Wednesday. The New York, NY based company plans to raise $36... Read >>

Renaissance Capital

NASH/HIV biotech Tobira Therapeutics revives IPO plans; updates financials and underwriters

Tobira Therapeutics, a biotech developing an immunotherapy treatment for liver disease ( NASH ) and HIV, revived plans for its upcoming IPO in an amendment filed on Tuesday with blank terms and... Read >>

Renaissance Capital

DBV Technologies prices US IPO at $21.64, below expectations

DBV Technologies, a French biotech developing immunotherapy patches that treat food allergies, raised $93 million by offering 4.3 million shares at $21.64, below its $23 proposed offer price. DBV... Read >>

Renaissance Capital

Put your back into it: The Joint sets terms for $30 million IPO

The Joint, which franchises 215 cash based chiropractic clinics in the US, announced terms for its IPO on Wednesday. The Scottsdale, AZ based company plans to raise $30 million by offering 3.0... Read >>

Renaissance Capital

Fifth Street Asset Management withdraws IPO, citing market volatility

Fifth Street Asset Management, a credit focused alternative asset manager with $5.6 billion in AUM, postponed its IPO on Wednesday citing market volatility. The Greenwich, CT based company was... Read >>

Renaissance Capital

Proteon Therapeutics prices IPO at $10, below the range

Proteon Therapeutics, which is developing a treatment to reduce the failure rates of a dialysis related procedure, raised $61 million by offering 6.1 million shares at $10, below the range of $12... Read >>

Renaissance Capital

Anchor BanCorp Wisconsin prices IPO at the $26 midpoint

Anchor BanCorp Wisconsin, the third largest bank headquartered in Wisconsin with 54 locations, raised $10 million by offering 0.4 million shares at $26, within the range of $25 to $27. Anchor... Read >>

Renaissance Capital

Micro-enterprise network CVSL sets terms for $60 million uplisting to the NYSE

CVSL, which acquires and improves the operations of small direct selling businesses, announced terms for its uplisting to the NYSE MKT on Tuesday. The Plano, TX based company plans to raise $60... Read >>

Renaissance Capital

Yeast infection biotech remains private: Viamet Pharmaceuticals withdraws $75 million IPO

Viamet Pharmaceuticals, a biotech developing metal binding protein therapeutics to treat fungal diseases, withdrew its plans for an initial public offering on Tuesday. Viamet's lead drug candidate... Read >>

Displaying 1-10 of 2826
<< first < previous 1 2 3 4 5 50 100 150 200 250 last >>